On the other hand, published evidence does not suggest any differences in GFAP between FTD and other major neurocognitive entities (e.g., DLB, PSP, CBS), with occasional results in favor of higher GFAP levels in DLB [47,64,127]. This evidence concerns the gene GFAP and Lewy body dementia.